Pacific Biosciences of California, Inc.
PACB
Key stats
- Open
- 1.99
- Day high
- 2.06
- Day low
- 1.80
- Previous close
- 2.09
- Volume
- 10.34M
- VWAP
- 1.95
- 52-week high
- 3.44
- 52-week low
- 1.07
- Market cap
- 652.57M
- Shares out
- 310.83M
- Employees
- 485
- Listed
- 2010
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
LABORATORY ANALYTICAL INSTRUMENTS · MENLO PARK, CA · pacb.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 19.8K
- Put open interest
- 6.6K
- Put/call
- 0.34
- At-the-money IV
- 126.6%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 2 put | 0.13 | Nov 12, 3:35 PM | 3.6K | 4.5K | 106.2% |
| 2 call | 0.12 | Nov 12, 3:35 PM | 360 | 3.6K | 126.6% |
| 3 call | 0.01 | Nov 12, 3:57 PM | 124 | 14.6K | 279.7% |
| 1.50 call | 0.54 | Nov 12, 9:33 AM | 100 | 479 | 294.2% |
| 3 put | 0.93 | Nov 11, 1:50 PM | 34 | 248 | — |
| 1.50 put | 0.12 | Oct 19, 2:59 PM | 7 | 7 | 295.7% |
Quarterly results
Massive · Nov 5, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $40.56M | $39.01M | $37.18M | $44.65M |
| Gross profit | $13.47M | $12.64M | $12.84M | $16.57M |
| Operating income | −$37.00M | −$44.61M | −$54.15M | −$41.20M |
| Net income | −$37.85M | −$44.74M | −$8.28M | −$40.37M |
| Diluted EPS | -0.12 | -0.14 | -0.03 | -0.13 |
| Operating cash flow | −$37.60M | −$35.58M | −$44.69M | −$19.07M |
| Assets | $721.10M | $751.85M | $782.37M | $784.08M |
| Liabilities | $782.48M | $785.06M | $780.00M | $778.73M |
| Equity | −$61.38M | −$33.21M | $2.37M | $5.35M |
Technicals
Massive · Nov 12, 2026- 50-day average1.99
- 200-day average1.60
- RSI (14 days)43.4
Short interest
Massive · Oct 30, 2026- Oct 30, 202653.68M shares · 4.1 days to cover
- Oct 15, 202646.93M shares · 2.2 days to cover
- Sep 30, 202647.22M shares · 3.0 days to cover
- Sep 15, 202648.89M shares · 10.5 days to cover
Related companies
MassiveNews coverage
No stories about Pacific Biosciences of California, Inc. right now.